Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Department of Medical Assistance Services; sickle cell disease; feasibility of Medicaid benefit and Medicaid Health Homes; report. Directs the Department of Medical Assistance Services to determine the feasibility of participating in an optional Medicaid benefit for sickle cell disease and establishing Medicaid Health Homes to coordinate care and provide treatment for individuals with sickle cell disease. The bill requires the Department to report its findings in its annual review of sickle cell disease treatment and submit such review to the Chairmen of the House Committee on Health and Human Services and the Senate Committee on Education and Health and the Joint Commission on Health Care by November 15, 2026.
Introduced
Jan 3, 2026
Last Action
Feb 18, 2026
Session
VA 2026
Sponsors
1 primary · 0 co
Left in Committee Appropriations
Subcommittee recommends laying on the table (7-Y 0-N)
Reported from Health and Human Services and referred to Appropriations (20-Y 2-N)
Assigned HAPP sub: Health & Human Resources
Subcommittee recommends reporting and referring to Appropriations (8-Y 0-N)
Assigned sub: Social Services
Fiscal Impact Statement from Department of Planning and Budget (HB136)
Prefiled and ordered printed; Offered 01-14-2026 26103032D
Referred to Committee on Health and Human Services
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
Left in Committee Appropriations
David A. Reid